Actinium Pharmaceuticals (ATNM)
(Delayed Data from AMEX)
$9.80 USD
-0.05 (-0.51%)
Updated May 17, 2024 04:00 PM ET
After-Market: $9.79 -0.01 (-0.10%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2024
Time: -- |
6/2024 | $-0.48 | 0.00% |
Earnings Summary
For their last quarter, Actinium Pharmaceuticals (ATNM) reported earnings of -$0.31 per share, beating the Zacks Consensus Estimate of $-0.42 per share. This reflects a positive earnings surprise of 26.19%. Look out for ATNM's next earnings release expected on August 12, 2024. For the next earning release, we expect the company to report earnings of -$0.48 per share, reflecting a year-over-year increase of 17.24%.
Earnings History
Price & Consensus
Zacks News for ATNM
Finch Therapeutics Group, Inc. (FNCH) Reports Q3 Loss, Misses Revenue Estimates
ATNM: What are Zacks experts saying now?
Zacks Private Portfolio Services